Trontinemab Clinical Trials (2026): 2 Studies for Alzheimers Disease

Where to Participate: All Trontinemab Trial Sites in the U.S. (68 sites across 25 states)

Every actively recruiting Trontinemabtrial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.

Trontinemab clinical trials at a glance: phase × recruitment status

Recruiting Trontinemab clinical trials (2)

Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).

Trontinemab pivotal trial highlights (Phase 2/3/4)

Phase-2/3/4 studies with named acronyms — the registration-grade trials most cited in label discussions and Wikipedia.

All Trontinemab trials (2)

Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.

Trontinemab clinical trials: frequently asked questions

How many Trontinemab clinical trials are there?

2 Trontinemab clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 2 are actively recruiting participants.

Are Trontinemab clinical trials recruiting in 2026?

Yes — 2 Trontinemab trials are actively recruiting in 2026, with 68 U.S. sites across 25 states. See the recruiting trials and the per-state site list further down this page.

What conditions is Trontinemab being studied for?

Trontinemab is being studied for Alzheimers Disease. The trials are grouped by indication on this page.

What phase is Trontinemab in?

Trontinemab clinical trials span 2 Phase 3. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.

Who sponsors Trontinemab clinical trials?

The lead sponsor across the most Trontinemab trials is Hoffmann-La Roche. Each trial row links to the full study detail page including sponsor information.

Sources and methodology

Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming Trontinemabas an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.

Last refreshed June 16, 2026.